The final injury phase for CBS from China creates immediate planning obligations for importers, rubber chemical users, customs brokers, and trade counsel. With a January 2027 hearing approaching and substantial countervailing duty exposure already in effect, affected companies should validate product scope, entry history, procedural deadlines, and recoverable ordinary duties.
What the Final ITC Phase Means for CBS Imports
The U.S. International Trade Commission has scheduled the final phase of antidumping and countervailing duty investigations covering n-cyclohexylbenzothiazole-2-sulfenamide from China. The proceedings are identified as Investigation Nos. 701-TA-797 for countervailing duties and 731-TA-1793 for antidumping duties.
The final phase focuses on whether a U.S. industry is materially injured or threatened with material injury because of the subject imports. It does not, by itself, establish dumping margins, subsidy rates, or a final duty order. Those determinations involve separate but coordinated responsibilities between the Department of Commerce and the ITC.
Lanxess Corporation filed the underlying petitions on May 7, 2026. Commerce has since made a preliminary affirmative countervailing duty determination, while the preliminary antidumping determination remained pending as of the scheduling announcement.
Commerce and ITC Decisions Must Be Evaluated Together
Commerce preliminarily assigned a 107.57 percent countervailing duty subsidy rate to Chinese producers and exporters. It also made an affirmative critical circumstances finding, creating potential retroactive suspension of liquidation and cash deposit exposure for entries made approximately 90 days before the preliminary determination.
For operational planning, companies may need to review entries dating to approximately July 10, 2026. The controlling date for any shipment should be confirmed against entry status and applicable Customs and Border Protection instructions rather than estimated from the general investigation timeline.
An affirmative final Commerce determination and an affirmative final ITC injury determination are generally required before an AD or CVD order can be issued. A negative final injury determination would generally prevent an order for the affected proceeding, subject to the specific results and administrative instructions. Until the process concludes, importers should continue managing deposits, liquidation status, and financial exposure conservatively.
Product Scope and Entry Exposure for Accelerator CZ
The covered product is n-cyclohexylbenzothiazole-2-sulfenamide, commonly abbreviated as CBS and also sold under names such as Accelerator CZ. Its Chemical Abstracts Service number is 95-33-0, and its chemical formula is C13H16N2S2. CBS is commonly used as an accelerator in tire manufacturing and other rubber compounding applications.
The product is typically imported as a powder or granule, but physical form alone does not determine scope treatment. CBS may also be imported in a solution containing substances such as benzene, ethanol, or acetone. The scope also includes CBS commingled with non-subject CBS, making composition and formulation data important for products that are mixtures or blended preparations.
The identified tariff classification is HTSUS subheading 2934.20.80. HTSUS classification provides an important screening tool, but the written product description generally controls the scope analysis. Merchandise entered under another classification may still be covered if it satisfies the written scope.
Build a Product-Level Exposure Map
Importers should map potentially covered merchandise using more than tariff numbers. A defensible review typically includes:
- CAS numbers and chemical formulas
- Accelerator CZ and other commercial names
- Supplier part numbers and internal SKUs
- Safety data sheets and certificates of analysis
- Product form, concentration, and carrier solvents
- Manufacturer and exporter identities
- Country of origin documentation
- Entry dates, liquidation status, and deposit amounts
Purchasing, trade compliance, finance, and customs teams should reconcile these data points. Product descriptions such as rubber accelerator or chemical preparation may not provide enough detail to identify CBS exposure.
Importers should also distinguish country of export from country of origin. Routing Chinese-origin CBS through another country, repackaging it, or invoicing it through a third-country seller does not necessarily change origin for AD/CVD purposes. Any origin determination should be supported by production records and a fact-specific assessment.
Key Deadlines and Compliance Actions
The ITC hearing is scheduled for January 14, 2027, at 9:30 a.m. Companies that manufacture, import, distribute, or consume CBS may have information relevant to injury, demand, pricing, substitutability, supply conditions, and downstream market effects. Participation requires careful attention to deadlines that begin before the hearing itself.
Final-Phase Investigation Calendar
The principal dates are:
- December 29, 2026: Prehearing staff report, initially nonpublic, with a public version expected afterward
- January 7, 2027: Prehearing briefs due
- January 8, 2027: Deadline to request an appearance at the hearing
- January 12, 2027, at 9:30 a.m.: Prehearing conference, if the ITC determines one is necessary
- January 13, 2027, at noon: Written testimony and presentation slides due
- January 14, 2027, at 9:30 a.m.: ITC hearing
- January 21, 2027: Posthearing briefs and nonparty statements due
- February 5, 2027: Commission information release
- February 9, 2027: Final comments due
Entries of appearance and applications for access under an administrative protective order are due no later than 21 days before the hearing. Filings are electronic through the ITC's Electronic Document Information System. Companies should not treat the January 8 request-to-appear deadline as a substitute for earlier appearance or protective-order requirements.
Coordinate Entry Controls With Financial Planning
Importers should monitor Commerce's companion antidumping investigation alongside the ITC calendar. The preliminary antidumping determination was scheduled no later than October 28, 2026, while the aligned final Commerce determinations were expected around January 11, 2027. Administrative schedules can change, so teams should maintain active deadline controls.
Cash deposits are not necessarily the final liability. Final assessment can depend on investigation outcomes, review proceedings, liquidation instructions, and importer-specific entry facts. Finance teams should model potential exposure separately from entered value and ordinary customs duty.
AD/CVD amounts must also be isolated in drawback calculations. Antidumping and countervailing duties are not eligible for drawback under 19 U.S.C. 1677h. Ordinary customs duties paid on the same entries may still qualify when the merchandise is subsequently exported or destroyed and all applicable drawback requirements are satisfied. Maintaining separate duty fields helps prevent ineligible AD/CVD amounts from being included in a claim while preserving potentially recoverable ordinary duties.
- On October 8, 2026, the U.S. Department of Commerce published its preliminary affirmative countervailing duty determination on n-cyclohexylbenzothiazole-2-sulfenamide (CBS) from China (C-570-235), assigning a uniform 107.57 percent subsidy rate to all Chinese producers and exporters (including Shandong Derek New Materials, Shandong Yanggu Huatai, and others, with several based on adverse facts available). Commerce also found critical circumstances, making cash deposit and suspension of liquidation requirements retroactive to around July 10, 2026, and aligned the final CVD determination with the companion AD case.
- On October 16, 2026, the U.S. International Trade Commission published notice in the Federal Register (91 FR 65776, FR Doc. 2026-21143) scheduling the final phase of investigations 701-TA-797 (CVD) and 731-TA-1793 (AD). The public hearing is set for January 14, 2027, at 9:30 a.m., with the prehearing staff report due December 29, 2026, prehearing briefs January 7, 2027, and posthearing briefs January 21, 2027. Commerce's AD preliminary determination remains pending.
- Commerce postponed its AD preliminary determination (A-570-234) to no later than October 28, 2026, following a timely request from petitioner Lanxess Corporation to allow time for analysis of potential export subsidies from the CVD case. Final Commerce determinations in both investigations are aligned for around January 11, 2027.
- Chinese chemical industry reports on October 8, 2026, highlighted the 107.57 percent CVD rate taking effect after Federal Register publication, with retroactive collection on uncleared entries from around July 8, 2026. They noted 2025 U.S. imports of CBS (rubber accelerator CZ) from China totaled approximately $12.23 million and flagged ongoing risks for exporters as the AD investigation proceeds.
Frequently Asked Questions
What Is CBS or Accelerator CZ?
CBS is n-cyclohexylbenzothiazole-2-sulfenamide, a chemical accelerator commonly used in rubber compounding and tire production. It is associated with CAS 95-33-0 and may be sold as Accelerator CZ or under related commercial names. It can appear as powder, granules, mixtures, or solutions.
Does HTSUS 2934.20.80 Automatically Determine Coverage?
No. HTSUS subheading 2934.20.80 is a key indicator for identifying potentially affected entries, but tariff classification is generally not dispositive in an AD/CVD scope analysis. The written scope, product chemistry, origin, form, and composition should be reviewed together.
Is the 107.57 Percent CVD Rate a Final Liability?
Not necessarily. The 107.57 percent rate is a preliminary cash deposit rate assigned to Chinese producers and exporters in the countervailing duty investigation. Final liability may change based on Commerce's final determination, the ITC's injury determination, subsequent proceedings, and liquidation instructions.
Why Does the Critical Circumstances Finding Matter?
An affirmative critical circumstances finding can extend suspension of liquidation and cash deposit requirements to qualifying entries made roughly 90 days before the preliminary determination. Importers should review entries from approximately July 10, 2026, while confirming the exact applicable date through entry-specific instructions and records.
Can AD/CVD Duties Be Recovered Through Duty Drawback?
No. Antidumping and countervailing duties are excluded from drawback. However, ordinary customs duties paid on the same entries may remain eligible when the imported merchandise, or qualifying substituted merchandise, is exported or destroyed and the claim satisfies the applicable requirements.
Should a CBS User Participate in the ITC Hearing?
Participation may be appropriate when an importer or downstream user has a material interest and relevant market information. Companies should consult trade counsel about party status, administrative protective order access, confidential information, briefing obligations, and hearing strategy well before the January deadlines.
How Stable Software Can Help
Keep Recoverable Duties Separate From AD/CVD
The CBS investigations illustrate why drawback calculations must distinguish ordinary customs duties from ineligible antidumping and countervailing duties. Customs brokers need a controlled process that preserves eligible duty recovery without including AD/CVD deposits in claims.
DrawbackAI is flat-license duty drawback software that U.S. customs brokers can white-label for importer clients. Brokers file under their own filer codes and retain control of the client relationship and filing process. Stable Software charges a flat software license and never takes a percentage of the refund. Brokers managing entries affected by the CBS investigations can evaluate DrawbackAI as part of a broader approach to separating duty types and supporting compliant drawback claims.
Resources
| Type | Resource |
|---|---|
| Source | Primary source |



